Effects of oxygen on zonal marker expression in human articular chondrocytes by Schrobback, Karsten et al.
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
Schrobback, K., Malda, J., Crawford, R. W., Upton, Z., Leavesley, D. I., &
Klein, T. J. (2012) Effects of oxygen on zonal marker expression in human
articular chondrocytes. Tissue Engineering Part A, 18(9-10), pp. 920-933.
This file was downloaded from: http://eprints.qut.edu.au/50407/
c© Copyright 2012 Mary Ann Liebert, Inc. Publishers
This is a copy of an article published in the Tissue Engineering Part A
(C) 2012 (copyright Mary Ann Liebert, Inc.); Tissue Engineering Part A is
available online at: http://www.liebertonline.com.
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
http://dx.doi.org/10.1089/ten.tea.2011.0088
Effects of Oxygen on Zonal Marker Expression in Human Articular 
Chondrocytes 
 
Karsten Schrobback, PhD (corresponding author) 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059 
Phone: +61731386000, fax: +61731386030 email: k.schrobback@qut.edu.au 
 
Jos Malda, MSc, PhD 
Department of Orthopaedics, University Medical Center Utrecht 
PO Box 85500, 3508 GA, Utrecht, The Netherlands 
phone: +31887558078, fax: +31302510638, email: jos@malda.nl  
and 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059. 
 
Ross William Crawford, MD, PhD 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059 
Phone: +61731394481, fax: +61731394043, email: r.crawford@qut.edu.au  
 
Zee Upton, PhD 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059 
Phone: +61731386185, fax: +61731386030, email: z.upton@qut.edu.au 
 
David Ian Leavesley, PhD 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059 
Phone: +61731386188, fax: +61731386030, email: d.leavesley@qut.edu.au 
 
Travis Jacob Klein, PhD 
Oxygen Effects on Zonal Markers in Human Chondrocytes 
2 
Institute of Health and Biomedical Innovation, Queensland University of Technology, 
60 Musk Ave, Kelvin Grove, Australia 4059 
Phone: +61731386142, fax: +61731386030, email: t2.klein@qut.edu.au 
 
Abstract 
Articular cartilage is organized in depth zones with phenotypically distinct 
subpopulations of chondrocytes that are exposed to different oxygen tensions. 
Despite growing evidence of the critical role for oxygen in chondrogenesis, little is 
known about its effect on chondrocytes from different zones. This study evaluates 
zonal marker expression of human articular chondrocytes from different zones under 
various oxygen tensions. Chondrocytes isolated from full-thickness, superficial and 
middle/deep cartilage from knee replacement surgeries were expanded and 
redifferentiated under hypoxic (5%O2) or normoxic (20%O2) conditions. 
Differentiation under hypoxia increased expression of hypoxia-inducible factors 
1alpha and 2alpha (HIF-1α/HIF-2α) and accumulation of extracellular matrix, 
particularly in middle/deep chondrocytes, and favored re-expression of proteoglycan 
4 (PRG4) by superficial chondrocytes compared to middle/deep cells. Zone-
dependent expression of clusterin varied with culture duration. These results 
demonstrate that zonal chondrocytes retain important phenotypic differences during 
in vitro cultivation, and that these characteristics can be improved by altering the 
oxygen environment. However, transcript levels for pleiotrophin, cartilage 
intermediate layer protein (CILP), and collagen type X (COL10A1) were similar 
between zones, challenging their reliability as zonal markers for tissue-engineered 
cartilage from osteoarthritis patients. Key factors including oxygen tension and cell 
source should be considered to prescribe zone-specific properties to tissue-
engineered cartilage. 
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Introduction 
Articular cartilage is stratified into zones delineated by characteristic changes in 
cellular, matrix and nutritive components (1). As a consequence, biochemical and 
biomechanical properties vary greatly between the different zones giving the tissue 
its unique structure and, thus, the ability to cope with extreme loading (2). Cartilage 
damage due to injuries and other debilitating conditions such as osteoarthritis, 
however, frequently leads to a loss of the tissue’s structure and function. 
Unfortunately, regenerative medicine-based approaches aiming to repair damaged 
cartilage have not yet achieved the consistency and effectiveness required for 
widespread clinical success (3). One potential explanation for this is that the de novo 
tissue lacks the zonal organization that appears critical for normal cartilage function 
(2).  
Chondrocytes from different zones exhibit distinct morphologies and protein 
expression. Therefore, engineering tissue with a zonal structure requires a thorough 
understanding of the in vitro behavior of zonal chondrocytes as well as a set of 
suitable markers that define their different phenotypes. The flattened cells of the 
superficial zone have been characterized by expression of specific proteins, such as 
clusterin (4) and proteoglycan 4 (PRG4) (5). Pleiotrophin, an embryonic growth and 
differentiation factor, has also been found in the superficial zone (6). The more 
spherical and randomly distributed chondrocytes from the middle layers have been 
found to specifically express cartilage intermediate layer protein (CILP) (7) and 
collagen type X, often used as a surrogate indicator of hypertrophy, is usually 
confined to the calcified, deeper regions of normal articular cartilage (8).  
Among zonal marker proteins, the zone-specific functions of PRG4 are most clearly 
understood. This highly glycosylated protein is secreted into the synovial cavity by 
cells lining the synovial joint (5, 9), where it plays a key role in boundary lubrication 
(10, 11). During osteoarthritis, PRG4 levels in affected joints are down-regulated, 
which potentially contributes to the progression of the disease (12). Consistent with 
this, treatment with recombinant PRG4 decreased cartilage degeneration in a rat 
model of osteoarthritis (13). PRG4 also has anti-adhesive properties which may 
inhibit integration of tissue-engineered constructs with native cartilage (14). 
Therefore, restoring in vivo stratification may have particular importance for the 
mechanical and metabolic properties of cartilaginous constructs. 
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The cells of different zones are exposed to different levels of nutrients due to the 
avascular nature of articular cartilage. For example, the oxygen partial pressure 
declines from ~7-10% at the superficial layer of articular cartilage to less than 1% 
near the subchondral bone (15). The response of chondrocytes to oxygen 
deprivation is regulated by the transcription factors of the hypoxia-inducible factor 
(HIF) family (16). HIF-1α appears to play a role in chondrocyte survival and energy 
generation (17, 18), whereas HIF-2α seems to control hypoxia enhanced 
chondrogenic differentiation (19). Despite the growing evidence for a critical 
influence of reduced oxygen on chondrogenesis (20), little is known about the zone-
specific effects of oxygen gradients. 
We hypothesized that chondrocytes exhibit a zone-specific response to oxygen 
concentration during in vitro redifferentiation and that the re-expression of specific 
markers of cartilage zones can be regulated by varying oxygen concentration. To 
test our hypothesis, we isolated and expanded human zonal articular chondrocytes 
and redifferentiated them in micromass pellets under normoxic (20% O2) and 
hypoxic (5% O2) conditions. Pellets were then assessed for DNA and 
glycosaminoglycan contents, HIF localization, and expression of zonal marker and 
matrix proteins.  
 
Materials and Methods 
Cell isolation  
Articular cartilage was obtained with ethics approval from femoral condyles of 
consenting patients (3 female donors, age 60-70 years) undergoing arthroplasties 
due to osteoarthritis. Tissue from macroscopically “normal” (International Cartilage 
Repair Society anatomical grade 0-1 (21)) regions of osteoarthritic cartilage were 
harvested. For zonal cartilage harvest, 6 mm cores were punched and approximately 
300-500 µm of the superficial layer was processed separately from the remaining 
middle/deep tissue. Cartilage slices were minced, washed in Dulbecco’s phosphate 
buffered saline (PBS) (Invitrogen, Carlsbad, CA) and digested overnight with 0.15% 
w/v collagenase type 2 (Worthington, Lakewood, NJ) in serum-free, low-D-glucose 
basal medium (Dulbecco’s Modified Eagle Medium supplemented with 4 mM L-
alanyl-L-glutamine, 1 mM sodium pyruvate, 10 mM N-(2-hydroxyethyl)piperazine-N′-
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(2-ethanesulfonic acid), 0.1 mM non-essential amino acids, 50 U/mL penicillin, 50 
µg/mL streptomycin (all Invitrogen) and 0.4 mM L-proline (Sigma, St. Louis, MO)). 
Additional cartilage specimens were frozen in Tissue-Tek™ O.C.T. compound 
(Sakura Finetek, Tokyo, Japan) for histological analysis. 
 
Cell expansion  
Freshly isolated chondrocytes were seeded at 3,000 cells/cm2 in tissue culture flasks 
(Nunc/Thermo Fisher, Waltham, MA) and cultured in low-glucose basal medium 
supplemented with 0.1 mM L-ascorbic acid (WAKO Chemical, Osaka, Japan) and 
10% fetal bovine serum (FBS) (Hyclone, Logan, UT) at 37˚C in a humidified 
5%CO2/95% air incubator. Medium was refreshed twice per week. Subconfluent 
cells were released from culture flasks by washing twice with PBS and incubating in 
0.25% trypsin with 1 mM ethylenediamine tetraacetic acid (EDTA) (Invitrogen) at 
37˚C for 5 min. Cells were counted with a NucleoCounter (Chemometec, Allerød, 
Denmark) and used for differentiation experiments after 3 passages. Population 
doubling times and total population doublings were calculated and compared 
between groups. 
 
Chondrogenic differentiation  
The redifferentiation capacity of the expanded chondrocytes was evaluated by pellet 
culture in serum-free chondrogenic media (high glucose basal medium 
supplemented with 1.25 mg/mL bovine serum albumin (BSA), 10-7 M 
dexamethasone, 1% v/v ITS+1 (all Sigma), 0.1 mM L-ascorbic acid (WAKO) and 
10 ng/mL transforming growth factor type beta 1 (TGF-β1) (Chemicon/MILLIPORE, 
Billerica, MA). Pellets were formed by centrifugation of 2.5 x 105 cells per well in 
PCR microplates (Axygen Scientific, Union City, CA) at 600 x g and transferred into 
24-well plates after day 3. Medium was refreshed twice per week. Pellets were 
cultured either at ~20% oxygen in a humidified CO2 incubator or at 5% oxygen in a 
ProOx C-Chamber (Biospherix, Redfield, NY) inside the same incubator over 28 
days. The partial oxygen tension in the ProOx chamber was maintained through an 
automatically controlled supply of 5%CO2/95%N2, which partially exchanged the gas 
in the chamber until 5% oxygen was reached.  
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DNA quantification 
The Quant-iT™ PicoGreen® dsDNA assay (Invitrogen) was used to quantify the 
DNA content in pellet cultures. Briefly, cell pellets were weighed and incubated 
overnight at 60˚C with 0.5 mg/mL proteinase K (Invitrogen) in a phosphate buffer 
(20 mM Na2HPO4, 30 mM NaH2PO4.H2O, 5 mM EDTA, pH 7.1). Samples were 
mixed with the dye solution and fluorescence was measured with a microplate 
reader (BMG Labtech, Offenburg, Germany) at 485 nm excitation and 520 nm 
emission. DNA content was calculated from λ phage DNA standards (Invitrogen).  
 
Quantification of glycosaminoglycans (GAG)  
The GAG content of the pellets was quantified using the 1,9-dimethylmethylene blue 
dye (DMMB). In brief, proteinase K-digested samples were mixed 1 in 10 with 46 µM 
DMMB chloride (Sigma) dissolved in a glycine buffer (40 mM glycine, 40 mM NaCl, 
0.002% m/v sodium azide, pH 3). Absorbance at 525 nm was measured in a 
microplate spectrophotometer (Bio-Rad Laboratories, Hercules, CA). GAG content 
was calculated from chondroitin-6-sulphate standards (Sigma). 
 
Messenger ribonucleic acid (mRNA) expression analysis by qRT-PCR 
qRT-PCR was applied to quantify mRNA levels in chondrocyte pellet cultures. Total 
RNA was isolated from pellet cultures using TRIzol® Reagent (Invitrogen) following 
the manufacturer’s protocol with modifications for high proteoglycan content. Briefly, 
after chloroform-guided phase separation, RNA was precipitated from the aqueous 
layer with 0.5 volumes of 2-propanol, 0.5 volumes of salt solution (1.2 M NaCl, 0.8 M 
sodium citrate) and 16 µg/mL linear polyacrylamide (Ambion, Austin, TX) at -80°C 
overnight. Pelleted RNA was washed with 70% ethanol and resuspended in water. 
Total RNA was quantified by UV spectroscopy. Only samples which had A260/A280 
ratios of at least 1.8 and passed the agarose tris hydroxymethylaminoethane-
acetate-EDTA gel analysis were used. 
Primers used in qRT-PCR are listed in Table 1. Samples with 300 ng of total RNA 
were treated with DNase I (Invitrogen) and reverse transcribed into complementary 
DNA (cDNA) with SuperScript™ III first-strand synthesis supermix (Invitrogen) 
following the manufacturer’s protocols. Absolute quantification was carried out using 
Oxygen Effects on Zonal Markers in Human Chondrocytes 
7 
standard curves (22). All reactions were performed in duplicate in 7.5 µL volumes in 
a 384-well plate using Express SYBR® GreenER™ qPCR supermix universal 
(Invitrogen) and a 7900HT fast real-time PCR system (Applied Biosystems, Foster 
City, CA). Reactions contained 1 X qPCR mix, 132 nM of each forward and reverse 
primers and 0.2 µL of undiluted cDNA. PCR amplification followed a three step 
cycling protocol with an initial 5 min incubation at 50ºC, 2 min denaturation at 95ºC 
and 40 cycles of 95ºC for 15 s and 60ºC for 30 s. Amplification of the correct 
sequence during real-time reactions was assessed by a post-amplification melt curve 
analysis. Real-time curves were analyzed with ABI Sequence Detection System 
software version 2.3 (Applied Biosystems). The cDNA copy number for each reaction 
was then calculated by direct comparison to the known standards and normalized to 
18S rRNA. Transcript levels of middle/deep and superficial chondrocytes of each 
data point were further normalized to mRNA levels of the respective full-thickness 
controls. 
 
Safranin O staining 
Sections from pellet cultures were stained with safranin O for GAG. Briefly, fresh 
frozen samples embedded in O.C.T. compound (Sakura Finetek) were cut to yield 
~5 µm thick sections. Sections were fixed with 100% cold acetone and stained using 
haematoxylin, fast green FCF (0.001% w/v) and safranin O (0.1% w/v) (all from 
Sigma) (23). Images were captured with a MicroPublisher 3.3 RTV (QImaging, 
Surrey, Canada) mounted on a microscope (BX41) (Olympus, Tokyo, Japan). 
 
Immunohistochemical and immunofluorescence analysis 
To determine the protein expression of PRG4, clusterin, collagen type I and type II, 
fresh-frozen sections from chondrocyte pellets and native osteoarthritic cartilage, 
which had been treated with 0.1 µM monensin (Sigma) in culture medium overnight 
(24), were fixed in 100% cold acetone for 15 min. Antigen retrieval was included in 
the collagen staining procedures by applying 0.1% w/v hyaluronidase (Sigma) in 
PBS for 20 min at 37°C before blocking sections wit h 2.5% normal horse serum 
(Vector laboratories, Burlingame, CA) for 20 min. Samples were incubated with 
antibodies against either lubricin (PRG4) (1 h at ~22ºC, 1:200, Abcam ab28484, 
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Sapphire Bioscience, Redfern, Australia), clusterin (2.5 h at ~22ºC, 2G7, 1:200, 
generous gift from Dr. Brendan Murphy (25)), collagen type I (overnight at ~4ºC, 
1:300, I-8H5, MP Biomedicals, Solon, OH) or type II (overnight at ~4ºC, 1:100, II-
II6B3, Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA) in a 
humidified chamber. Control samples were probed in parallel with IgG isotype control 
antibodies (rabbit IgG, 1:1000, Abcam ab37415, Sapphire Bioscience; mouse IgG, 
1:500, Invitrogen). Subsequently, biotinylated secondary anti-rabbit/mouse antibody 
(Vector) was applied to the sections for 30 min, followed by incubation with avidin 
and biotinylated horseradish peroxidase complex reagent (Vector) for 30 min in a 
humidified chamber. A 5 min wash in PBS was performed after each step. 
Chromogens were allowed to develop over 5 min by using ImmPACT™ DAB 
Substrate (Vector). Samples were rinsed with tap water for 5 min and counterstained 
in Mayer’s haematoxylin (Amber Scientific, Midvale, Australia). Images of samples 
were captured, as described above. 
To determine the protein expression of HIF-1α and HIF-2α, fresh-frozen sections 
from chondrocyte pellets were fixed in 100% cold acetone for 15 min, blocked with 
2% w/v BSA / 0.1% v/v Triton X-100 in PBS for 20 min and probed with antibodies 
against either HIF-1α or HIF-2α (1 h at ~22ºC, 1:100, Novus Biologicals NB100-
105/NB100-122, Sapphire Bioscience). Subsequently, samples were incubated with 
AlexaFluor®488-labelled secondary antibodies (for HIF-1α, anti-mouse, Invitrogen; 
for HIF-2α, anti-rabbit, Cell Signaling, Danvers, MA; both 1:400) and 5 µg/mL 4′,6-
diamidino-2-phenylindole (DAPI, Sigma) for 1h at room temperature. Control 
sections were treated similarly without incubation with a primary antibody. Images 
were captured with fixed exposure times on an Axio Imager.A1 microscope with epi-
fluorescence attachment (Carl Zeiss, Jena, Germany). 
 
Western blot analysis  
To test for the amount of PRG4 protein secreted by chondrocytes into the media, 
conditioned media was collected and pooled from pellets of zonal chondrocytes 
during week 4 of differentiation culture. Proteins in the media were concentrated by 
acetone precipitation and their amounts quantified by Bradford assay (Sigma). 
Protein samples, a control of recombinant human lubricin (~240 kDa, characterised 
in (13), generous gift of Dr. Eric Vanderploeg, Pfizer Inc., USA) and a molecular 
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weight marker standard (Bio-Rad) were mixed non-reduced with NuPAGE® LDS 
Sample Buffer (Invitrogen), electrophoresed on a NuPAGE® Novex 3-8% Tris-
Acetate gel (Invitrogen) (100 µg protein or 2.5 µg LUB1 per lane) and transferred 
onto a nitrocellulose membrane (PALL, Pensacola, FL). The membrane was blocked 
with 2% w/v skim dry milk in a solution of Tris-buffered saline/Tween-20 (TBST) and 
probed with a lubricin antibody (over night at 4ºC, 1:1000, Abcam ab28484) and 
HRP-conjugated anti-rabbit antibody (45 min at ~22ºC, 1:4000, Abcam ab6721/ 
Sapphire Bioscience Pty Ltd). Membrane was then incubated in ECL substrate 




Statistical analyses were performed using Minitab 15.1 software (Minitab Inc., State 
College, PA). Analysis of variance was conducted using a general linear model in 
which donor was considered a random effect. To test the effect of cell harvest site or 
oxygen levels during differentiation, data from day 0 were excluded. The effect of 
cultivation time was tested for each differentiation condition separately including day 
0 data. In addition, data sets from each individual time point were tested separately 
for statistical significance. If significant differences were detected between 
conditions, Tukey’s post-hoc tests were performed. Statistically significant 
differences were considered to be present at p<0.05.  
 
Results 
Propagation of zonal chondrocytes 
Population doubling times were not significantly different between chondrocytes from 
full-thickness (3.5 ±0.2 days), superficial zone (3.8 ±0.3 days) or middle/deep zones 
(4.1 ±0.04 days) during monolayer propagation (p=0.1). Chondrocytes from the 
different experimental groups had gone through similar population doublings before 
redifferentiation (full-thickness: 8.1 ±0.7; superficial 7.5 ±1.7; middle/deep: 6.9 ±1.0) 
(p=0.1). 
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Expression of HIF-1α and HIF-2α and redifferentiation of zonal chondrocytes 
The effect of different oxygen tensions was assessed by immunofluorescence 
staining for HIF-1α and HIF-2α. Immuno-reactivity for both HIFs appeared to be 
weaker and more diffuse in sections from normoxia samples compared to those from 
hypoxia samples; here shown for full-thickness chondrocytes (Fig. 1). Staining was 
observed to be localized in the cytosol of the cells cultured under ambient oxygen. In 
contrast, in chondrocytes differentiated under 5% O2, most intense staining was 
peripheral to their nuclei. Under low oxygen, immuno-reactivity for both HIFs was 
found to be more strongly associated with the nuclei in middle/deep cells, compared 
with full-thickness and superficial zone chondrocytes. Staining intensity for HIF-1α 
was highest near the center of the pellets cultured under hypoxia. 
Wet weight, DNA and GAG content was determined to compare the chondrogenic 
potential of zonal chondrocytes under various oxygen tensions. Oxygen tension 
during redifferentiation had a significant effect on pellet wet weight (p<0.001) and 
DNA content (p<0.01), as well as GAG content normalized to DNA (GAG per DNA) 
(p<0.001) (Fig. 2). There were no differences in DNA content (p=0.3) of pellets from 
the various harvest zones/sites (Fig. 2 A). However, chondrocytes harvested from 
middle/deep zone cartilage showed overall higher pellet wet weights than 
chondrocytes from full-thickness cartilage (p<0.01). Moreover, middle/deep 
chondrocytes also produced overall more GAG per DNA compared to superficial 
(p<0.05) and full-thickness chondrocytes (p<0.001) (Fig. 2 B,C). DNA content and 
pellet wet weight remained stable over the differentiation period under normoxic and 
hypoxic conditions (Fig. 2 A,B), yet there was a trend of increasing pellet wet weights 
under 5% oxygen between day 7 and day 28 (Fig. 2 B). Under 20% oxygen tension, 
higher levels of GAG per DNA were present in pellets from full-thickness and 
superficial chondrocytes at day 14 as well as in full-thickness and middle/deep 
chondrocytes cultures at day 28 compared to day 0 (p<0.05) (Fig. 2 C). Increased 
levels of GAG per DNA were also found under hypoxic conditions in pellets from 
middle/deep and superficial chondrocytes at day 14 and 28 compared to day 0 
(p<0.05).  
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Expression of genes induced during dedifferentiation or chondrogenesis 
Expression of marker genes of chondrogenesis and dedifferentiation were assessed 
using qRT-PCR. Reduced oxygen tension tended to increase the overall mRNA 
expression of the chondrogenic markers aggrecan and collagen type II (COL2A1), 
however, this was not significant for full-thickness chondrocytes (p=0.1) (Fig. 3 A). At 
normoxic conditions, aggrecan expression was lower in full-thickness chondrocytes 
at day 28 compared to day 0 (p<0.01), but remained unaltered under low oxygen. 
Transcript levels of the dedifferentiation marker versican were higher at normoxic 
compared to hypoxic conditions (p<0.05) (Fig. 3 B). However, mRNA expression of 
collagen type I (COL1A1), another dedifferentiation marker was not affected by the 
oxygen environment (p=0.2). 
To account for donor-related differences in chondrogenic potential of the samples, 
the mRNA data from superficial and middle/deep chondrocytes were normalized to 
mRNA levels from full-thickness chondrocytes. Regardless of oxygen tension and 
culture times, no differences in the mRNA expression levels of chondrogenic and 
dedifferentiation markers were detected between cells from the middle/deep and 
superficial zones (Fig. 3 C,D). 
 
Matrix synthesis during redifferentiation  
The synthesis of cartilaginous matrix in pellet cultures was assessed by staining with 
safranin O (GAG) and by probing with antibodies specific for collagen type I and II. 
Pellets cultured under ambient oxygen exhibited weak staining for GAG and 
immunoreactivity for collagen type II, in contrast to pellets cultured under reduced 
oxygen (Fig. 4). Cells cultured at normoxic conditions, particularly from full-thickness 
and superficial samples, appeared to be more densely packed in the center of the 
pellets and were surrounded by minimal extracellular matrix, which immuno-reacted 
predominantly for collagen type I. At hypoxic conditions, the extracellular matrix of 
samples from middle/deep zone chondrocytes yielded the most intense immuno-
reactivity staining for GAG and collagen type II. All pellets exhibited a superficial rim 
of multiple layers of flattened, elongated cells. The tissue in the outer layers stained 
weakly with safranin O and immuno-reacted non-uniformly for collagen type I. In 
general, samples from all conditions immuno-reacted positively for collagen type I. 
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Interestingly, the matrix of osteoarthritic cartilage immuno-reacted not only for 
collagen type II but also for collagen type I, localized primarily to the superficial zone. 
 
Expression of zonal marker genes during redifferentiation 
The expression of putative zone-specific genes of the superficial zone (PRG4, 
clusterin, pleiotrophin) was assessed by qRT-PCR. For full-thickness chondrocytes, 
PRG4 mRNA was undetectable after four weeks of monolayer propagation (Fig 5 A). 
It was re-expressed after 7 days of pellet culture at 5% oxygen tension (p<0.05). 
However, after 28 days, PRG4 expression decreased again (p<0.05). Clusterin 
levels were only significantly higher at day 28 compared to day 0 (p<0.01) and day 7 
(p<0.05) under hypoxic conditions. Pleiotrophin expression remained unchanged 
over the entire culture period. However, transcript levels of this molecule were 
overall higher at hypoxic compared to normoxic conditions (p<0.05).  
PRG4 expression was higher in superficial chondrocyte pellets compared to those 
from middle/deep cells at day 7 (p<0.05) and at day 28 (p<0.01) under 5% oxygen 
tension (Fig. 5 C). Expression levels for clusterin were also elevated in superficial 
chondrocytes compared to middle/deep cells under hypoxic conditions, however, 
only at day 7 (p<0.05). There was no difference in transcript levels between 
superficial and middle/deep cells for pleiotrophin at any time point or oxygen tension. 
The middle zone marker CILP and deep zone marker collagen type X (COL10A1) 
were not detected at the start of the pellet culture (Fig. 5 B). CILP was re-expressed 
after 7 days of full-thickness chondrocyte pellet culture at 5% oxygen tension 
(p<0.05). However, COL10A1 transcript levels increased only after 28 days under 
normoxic conditions compared to day 0 (p<0.05). Oxygen tension did not influence 
CILP (p=0.4) or COL10A1 (p=0.1) transcription. Irrespective of culture time, no 
differences in the mRNA expression levels of middle/deep markers were detected 
between cells from the middle/deep and superficial zones in response to different 
oxygen tensions (Fig. 5 D). 
 
PRG4 and clusterin synthesis during redifferentiation 
To confirm protein synthesis of PRG4 and clusterin, sections of pellets after 28 days 
in culture and conditioned media of week 4 of culture were analyzed by 
Oxygen Effects on Zonal Markers in Human Chondrocytes 
13 
immunohistochemistry and Western blotting, respectively (Fig. 6). Pellets 
redifferentiated at normoxic conditions exhibited only faint or no immuno-reactivity for 
PRG4 (Fig. 6 A). In contrast, pellets cultured at hypoxic conditions with superficial 
cells exhibited intense immuno-reactivity for PRG4. Pellets from full-thickness and 
middle/deep chondrocytes cultured under hypoxia also immuno-reacted positively for 
PRG4, but less intensely than the pellets from superficial cells. Surprisingly, immuno-
reactivity in these tissues appeared to be confined to the extracellular matrix near the 
center of the pellet. Conversely, PRG4 in monensin-treated osteoarthritic cartilage 
was localized to the outermost boundary of the superficial zone and to cells within 
this layer. Faint positive immuno-reactivity for clusterin was detected in all section 
without clear differences between samples from the various oxygen conditions or 
tissue origins. Immuno-reactivity was confined to intra-/pericellular areas of cells 
scattered throughout the sections. Immunoblotting of conditioned pellet media 
revealed higher levels of PRG4 secreted by pellets derived from superficial 
chondrocytes under 5% oxygen in contrast to middle/deep or full-thickness cells. 
PRG4 was undetectable in all in media of cells cultured under ambient oxygen. (Fig. 
6 B). Recombinant lubricin appeared as a broad band around 250 kDA and showed 
a second narrow band below 37 kDa as well as an additional band in the higher 
molecular weight range, which was described as the dimer of the 240 kDa lubricin 
monomer by others (13).  
 
Discussion 
The aim of this study was to evaluate the effect of oxygen tension on chondrocytes 
from the different zones (“normal” full-thickness, superficial and middle/deep) of 
human articular cartilage. We observed that zonal chondrocytes retain phenotypic 
differences during in vitro cultivation. Of the putative zonal markers investigated 
here, only the expression of PRG4 appeared to be zone-specific, which was favored 
by low oxygen tension. We generally found that moderate hypoxia enhanced the 
expression of hypoxia-inducible factors along with the synthesis of extracellular 
matrix and chondrogenic marker proteins in all chondrocytes during in vitro 
redifferentiation. However, the positive effect of hypoxia on chondrogenesis was 
superseded by donor-specific limited redifferentiation capacity, as reported by others 
(26). In agreement with several other studies, chondrocytes isolated from the 
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middle/deep zone synthesized the most matrix compared to cells from other harvest 
sites (24, 27-30). Immunostaining for HIF-1α and HIF-2α showed a clear oxygen-
dependent expression pattern in all pellets at day 28 with both transcription factors 
only localized peripheral to the nuclei under hypoxic conditions. Moreover, HIF 
staining in these cultures appeared stronger toward the center of the pellets, which is 
consistent with decreasing oxygen concentrations as confirmed for cartilaginous 
tissue-engineered constructs elsewhere (31).  
To characterize the phenotypic differences of the in vitro cultivated zonal 
chondrocytes in more detail, we investigated the expression of proteins that are 
specifically synthesized in different zones of articular cartilage. Only chondrocytes in 
the superficial layer of normal cartilage express PRG4 (5). PRG4 expression is lost 
together with the chondrocyte phenotype during prolonged monolayer cultivation, as 
observed in our study and elsewhere (32). However, PRG4 was re-expressed in 
pellet culture, particularly at reduced oxygen tension. Interestingly, in spite of 
equivalent or slightly reduced levels of HIF-1α and HIF-2α in superficial cells, they 
exhibited higher levels of PRG4 transcripts than middle/deep cells, which argues 
against a direct involvement of the HIFs and, hence, of hypoxia in the expression of 
this zonal marker. The presence of PRG4 in the middle/deep cells may be due to 
induction of this gene in cells that were originally PRG4-negative (33). There is 
evidence that certain cytokines, such as TGF-β, IL-1α/β and potentially IGF-1, 
modulate its metabolism (34-36). In our study, PRG4 transcript levels reflected the 
general expression trends of chondrogenic markers, particularly collagen type II with  
slightly decreased transcription after four weeks even when cultivated at low oxygen. 
This suggests that conditions that generally favor chondrogenesis influence PRG4 
synthesis only in chondrocytes from the superficial zone, and that prolonged 
exposure to TGF-β and hypoxia is not sufficient to maintain neither the expression of 
chondrogenic markers nor PRG4 synthesis in vitro. Surprisingly, cells in the center of 
the pellets immuno-reacted more intensely for PRG4 than in the periphery. As it is 
unlikely that oxygen and nutrient gradients in pellets act contrarily to the situation in 
vivo, they may be less important to PRG4 metabolism within pellets. This is also 
supported by the observation of PRG4-positive, ectopic chondrocyte aggregates in 
exposed subchondral bone of osteoarthritic human knees (37). The gradient in 
immuno-reactivity intensity in the pellets could be the result of diffusion of PRG4 
from outer layers of pellets into the surrounding medium, which unlike synovial fluid 
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has a low PRG4 concentration. Testing the conditioned culture media for PRG4 
protein by Western Blotting confirmed, indeed, higher levels of PRG4 secreted by 
pellets derived from superficial chondrocytes under 5% oxygen in contrast to 
middle/deep cells or the same cells cultured under ambient oxygen (Fig. 6 B). 
Another putative marker protein for the superficial zone of cartilage is clusterin (4, 
38). Clusterin is often found at fluid-tissue interfaces suggesting a potential role in 
cell membrane protection from the damaging effects of various secretions (39). 
Consequentially, it is confined to the superficial layer of cartilage (4, 38). However, 
clusterin is up-regulated in early osteoarthritis, not only in the superficial layers (40). 
In this study, clusterin synthesis appeared to increase over pellet culture time and 
superficial chondrocytes expressed higher levels of this molecule at day 7 under 5% 
oxygen compared to middle/deep cells. However, this zone-specific difference was 
lost at day 28 as shown on mRNA and protein level. Elevated levels in middle/deep 
chondrocytes at later time points could be attributed to the osteoarthritic nature of the 
cells, but may also be related to the increasing stress, which cells certainly 
experience ex vivo in the serum-free pellet culture model. Interestingly, Schuurman 
et al. (30) found zone-specific synthesis of clusterin in equine articular chondrocytes 
cultured in alginate cultures but no zonal differences when using pellet cultures. 
Moreover, our use of TGF-β1 could have played a role in the up-regulation of 
clusterin, as this growth factor is known to induce clusterin expression in epithelial, 
endothelial and fibroblast cell lines (41, 42). Given that clusterin is involved in many 
cellular processes and that its zone-specific expression by chondrocytes appears to 
be dependent on the in vitro culture system, this protein might not be a suitable 
marker of zonal stratification in tissue-engineered cartilage. 
Along with the above mentioned “classic” markers of the superficial zone of cartilage, 
we also determined the expression of pleiotrophin (PTN), an embryonic growth and 
differentiation factor, which is re-expressed in early osteoarthritis, mainly in the 
superficial zone (6). Our data failed to indicate a zone-dependent expression of the 
molecule. However, we observed elevated transcription of PTN under moderate 
hypoxia, which is consistent with observations made in other cell types (e.g., 43). A 
low oxygen environment could also indirectly affect PTN expression through the 
promotion of chondrogenesis. In fact, PTN itself can enhance chondrogenesis and 
proteoglycan synthesis by chondrogenic cells in vitro in a paracrine/autocrine 
manner (44). On the other hand, in mouse growth plates PTN is primarily localized in 
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hypertrophic chondrocytes, pointing to its known role as an pro-angiogenic agent 
(45). However, there is no apparent link between PTN expression and hypertrophy, 
when comparing the expression profiles of PTN and hypertrophy-associated 
COL10A1. In general, pleiotrophin appears more likely to be involved in repair and 
protection processes related to osteoarthritis (6), where it reportedly reduces 
expression of catabolic factors (46). PTN’s precise role in chondral ossification and 
the course of osteoarthritis requires further investigation. 
CILP is a protein thought to be specifically expressed by middle and deep zone 
chondrocytes (7, 47). It was proposed that CILP is involved in regulating extracellular 
levels of inorganic pyrophosphate and the deposition of calcium pyrophosphate 
dehydrate crystals in articular cartilage, which takes place predominantly in the 
middle/deep zone of aging tissue (48). Although depth-dependent expression of 
CILP appeared to be conserved in cartilage affected by osteoarthritis (49), we did not 
observe zone-specific CILP expression in our study. However, we did find that CILP 
expression was culture model-dependent, with major up-regulation during pellet 
culture. Indeed, there is evidence that CILP protein expression in chondrocytes is 
induced by TGF-β1 (48, 50). The increased expression of CILP in our model raises 
the question of whether calcium pyrophosphate dehydrate crystal deposition was 
also elevated, which would potentially have adverse effects on the quality of 
engineered cartilage.  
In conclusion, in vitro cultured, dedifferentiated zonal chondrocytes re-express 
phenotypic differences during redifferentiation. Low oxygen tension favors re-
expression of PRG4 in superficial cells, most likely through promoting overall 
chondrogenesis. This underlines the importance of considering zonal differences 
when creating native-like cartilaginous constructs. Of course, the zonal harvest of 
autologous chondrocytes poses some practical challenges that are still to be 
overcome. In this respect, zonal cartilage tissue engineering could be even more 
applicable to non-osteoarthritic joints where more tissue is available and zonal 
harvest potentially easier. An additional challenge is that, dependent on the specific 
culture conditions, some putative zonal markers, especially those involved in various 
cellular processes, might not be expressed exclusively by specific subpopulations of 
chondrocytes ex vivo, and, thus, are not reliable predictors of in vitro stratification. 
Therefore, more robust zonal markers, in particular for middle/deep chondrocytes, 
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COL1A1 F: CAGCCGCTTCACCTACAGC NM_000088 4335-4417 
(51) R: TTTTGTATTCAATCACTGTCTTGCC   
COL2A1 F: GGCAATAGCAGGTTCACGTACA NM_001844 4454-4532 
(51) R: CGATAACAGTCTTGCCCCACTT   
COL10A1 F: ACCCAACACCAAGACACAGTTCT NM_000493 201-264   
(52) R: TCTTACTGCTATACCTTTACTCTTTATGGTGTA   
ACAN F: GCCTGCGCTCCAATGACT NM_001135 739-844 
 R: TAATGGAACACGATGCCTTTCA   
VCAN F: CTGGATGGTGATGTGTTCCAC NM_004385 1061-1139 
 R: CCTGGTTTTCACACTCTTTTGC   
PRG4 F: GAGTACCCAATCAAGGCATTATCA NM_005807 3431-3510 
 R: TCCATCTACTGGCTTACCATTGC   
CILP F: GCAAAAGCATCCTGAAGATCAC NM_003613 993-1107 
 R: GGAGTCTCTGCCCTCACAAAC   
CLU F: CTATCTGCGGGTCACCACG NM_001831 1331-1402 
(53) R: ACCACCTCAGTGACACCGGA   
PTN F: AACTGACCAAGCCCAAACCT NM_002825 791-857 
 R: TTCTCCTGTTTCTTGCCTTCC   
18S rRNA F: GATCCATTGGAGGGCAAGTCT NR_003286 589-691 
 R: CCAAGATCCAACTACGAGCTTTTT   
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Fig 1: Immunofluorescence for HIF-1α or HIF-2α in pellet cultures of zonal 
chondrocytes redifferentiated under normoxic (20% O2) or hypoxic (5% O2) 
conditions. Following expansion, micromass pellets of cells (2.5 x 105) from full-
thickness, superficial and middle/deep zone cartilage were cultured under hypoxic or 
normoxic conditions, respectively, in serum-free chondrogenic media for up to 28 
days. Samples from pellet cultures were processed for fresh-frozen tissue 
immunofluorescence at day 28. Sections were probed with antibodies specific for 
HIF-1α or HIF-2α (green) and counterstained with DAPI (blue). Control sections 
without primary antibody incubation were included (red-framed inset). The figure 
presents samples representative of the experiments with cells from 3 patients. 
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Fig 2: (A) DNA content, (B) wet weight and (C) GAG content normalized to DNA from 
redifferentiation pellet cultures of chondrocytes from full-thickness, superficial and 
middle/deep zone cartilage cultured under hypoxic (5% O2) or normoxic (20% O2) 
conditions, respectively, in serum-free chondrogenic media for up to 28 days. 
Results for DNA content, wet weight and GAG content are expressed as mean + or - 
standard error (n = 3 donors). # = p<0.05 versus day 0. † = p<0.05. 20% O2 versus 
5% O2 was p<0.01 for DNA content and p<0.001 for wet weight and GAG content. 
Middle/deep vs. superficial was p<0.05 for GAG/DNA. Middle/deep vs. full-thickness 
was p<0.01 for wet weight and p<0.001 for GAG/DNA 
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Fig 3: Expression of (A, C) chondrogenic marker genes aggrecan (ACAN), collagen 
type II (COL2A1) and (B, D) dedifferentiation markers versican (VCAN) and collagen 
type I (COL1A1) in (A, B) full-thickness chondrocytes or (C, D) superficial and 
middle/deep chondrocytes. Total RNA was isolated from pellets of chondrocytes 
from full-thickness, superficial and middle/deep zone cartilage at the start of the 
differentiation and after 7 or 28 days in chondrogenic pellet culture. The mRNA 
expression of each target gene was determined by qRT-PCR with reference to a 
specific gene standard and normalized to the 18S rRNA. (C, D) Transcript levels of 
middle/deep and superficial chondrocytes of each data point were further normalized 
to mRNA levels of the respective full-thickness controls which are represented by a 
dashed line. Data are represented as mean + standard error (n = 3 donors). * = 
p<0.05, # = p<0.05 versus day 0. 
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Fig 4: Histology and immunohistochemistry on pellet cultures of zonal chondrocytes 
redifferentiated under normoxic (20% O2) or hypoxic (5% O2) conditions. Samples 
from redifferentiation pellet cultures (full-thickness, superficial and middle/deep zone 
cartilage) were processed for fresh-frozen tissue (immuno)histology at day 28. 
Sections were either stained with safranin O (red) and Fast Green or probed with 
specific antibodies against collagen type II (COLII, brown) or collagen type I (COLI, 
brown) and counterstained with haematoxylin. Sections from monensin-treated 
native cartilage (macroscopically normal site of osteoarthritic (OA) tissue) were 
included for comparison. The figure presents samples representative of the 
experiments with cells from 3 patients. Scale bars = 50 µm. 
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Fig 5: Expression of genes of (A, C) superficial zone markers proteoglycan 4 
(PRG4), clusterin (CLU) and pleiotrophin (PTN) and (B, D) middle/deep zone 
markers cartilage intermediate layer protein 1 (CILP) and collagen type X 
(COL10A1) in (A, B) full-thickness chondrocytes or (C, D) superficial and 
middle/deep chondrocytes. Total RNA was isolated from pellets of chondrocytes 
from full-thickness, superficial and middle/deep zone cartilage at the start of the 
differentiation and after 7 or 28 days in chondrogenic pellet culture. The mRNA 
expression of each target gene was determined by qRT-PCR with reference to a 
specific gene standard and normalized to the 18S rRNA. (C, D) Transcript levels of 
middle/deep and superficial chondrocytes of each data point were further normalized 
to mRNA levels of the respective full-thickness controls which are represented by a 
dashed line. Data are represented as mean + standard error (n = 3 donors).* = 
p<0.05, # = p<0.05versus day 0, † = p<0.05 versus day 7. 
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Fig 6: (A) Immunohistochemistry for superficial zone markers and (B) Western blot 
analysis of PRG4 in conditioned media from pellet cultures of chondrocytes form full-
thickness (F), superficial (S) and middle/deep (M) zone of cartilage redifferentiated at 
normoxic (20% O2) or hypoxic (5% O2) conditions. Samples from pellet cultures were 
processed for fresh-frozen tissue immunohistochemistry at day 28. Sections were 
probed with antibodies specific for PRG4 (brown) or clusterin (brown) and 
counterstained with haematoxylin. Sections from monensin-treated native cartilage 
(macroscopically normal site of osteoarthritic tissue) and pellet sections probed with 
unspecific IgG antibodies (IgG) are shown for comparison. Scale bars = 50 µm. 
Conditioned media of chondrocyte pellet cultures pooled from week 4 of culture were 
subjected to electrophoresis and immunoblotting with a PRG4 antibody. A 
recombinant human lubricin protein construct (~240 kDa) served as control (CTL). 
The figure presents samples representative of the experiments with cells from 3 
patients.  
 
